UBS Group AG Acquires Significant Stake in Australian Clinical Labs
Company Announcements

UBS Group AG Acquires Significant Stake in Australian Clinical Labs

Australian Clinical Labs Ltd (AU:ACL) has released an update.

UBS Group AG has become a substantial shareholder in Australian Clinical Labs Ltd, with a 6.41% voting power from holding over 12.9 million ordinary shares. This substantial stake highlights UBS’s significant influence in the company, involving various branches and fund management entities across Australia and Switzerland.

For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App